Uncovering molecular events associated with the chemosuppressive effects of flaxseed: a microarray analysis of the laying hen model of ovarian cancer
© Hales et al.; licensee BioMed Central Ltd. 2014
Received: 27 November 2013
Accepted: 5 June 2014
Published: 24 August 2014
The laying hen model of spontaneous epithelial ovarian cancer (EOC) is unique in that it is the only model that enables observations of early events in disease progression and is therefore also uniquely suited for chemoprevention trials. Previous studies on the effect of dietary flaxseed in laying hens have revealed the potential for both amelioration and prevention of ovarian cancer. The objective of this study was to assess the effect of flaxseed on genes and pathways that are dysregulated in tumors. We have used a bioinformatics approach to identify these genes, followed by qPCR validation, immunohistochemical localization, and in situ hybridization to visualize expression in normal ovaries and tumors from animals fed a control diet or a diet containing 10% flaxseed.
Bioinformatic analysis of ovarian tumors in hens led to the identification of a group of highly up-regulated genes that are involved in the embryonic process of branching morphogenesis. Expression of these genes coincides with expression of E-cadherin in the tumor epithelium. Levels of expression of these genes in tumors from flax-fed animals are reduced 40-60%. E-cadherin and miR200 are both up-regulated in tumors from control-fed hens, whereas their expression is decreased 60-75% in tumors from flax-fed hens. This does not appear to be due to an increase in ZEB1 as mRNA levels are increased five-fold in tumors, with no significant difference between control-fed and flax-fed hens.
We suggest that nutritional intervention with flaxseed targets the pathways regulating branching morphogenesis and thereby alters the progression of ovarian cancer.
KeywordsOvarian cancer Laying hen Flaxseed Branching morphogenesis
One out of 71 women will develop ovarian cancer in her lifetime. The five year survival rate is less than 44%, making ovarian cancer the most lethal gynecologic malignancy. This number has not changed significantly in the last 20 years in spite of advances in platinum-based chemotherapy . For this reason, there is a critical need to explore effective chemoprevention strategies.
It has been estimated that at least 30% of all cancers could be prevented through diet, exercise, and maintaining a healthy weight . One outcome of this approach is the reduction of the chronic, low-grade systemic inflammation that accompanies obesity. Chronic inflammation has been implicated to play a causative role in many diseases, including cancer . Further reduction of inflammation can be achieved by lowering the ratio of omega-6 to omega-3 fatty acids. The modern western diet contains a high ratio of omega-6 to omega-3 fatty acids, a profile that is both pro-inflammatory and oxidant-rich and creates an environment conducive to the development of disease. Flaxseed is one of the richest plant sources of omega-3 fatty acids. In addition, flaxseed also contains lignans, a class of phytoestrogens that also act as antioxidants . These two different nutriceuticals have pathway-specific actions, targeting inflammation and oxidative damage.
Research into the etiology of ovarian cancer has been limited by the lack of suitable animal models. The laying hen is a robust model in that ovarian cancer develops spontaneously with pathological and histological presentation very similar to human disease [5, 6]. As in women, the average age of onset occurs later in reproductive life, with 40% of hens having the disease by six years of age . The disease can progress rapidly, with transcoelomic spread disseminating from the ovary to organs and peritoneal surfaces, and with the accumulation of ascites. The four histotypes observed in human are represented in the hen, although the endometrioid type is the predominant form found in the hen whereas the serous type is most prevalent in women . Mutations in p53 are common in epithelial ovarian cancer (EOC) from both species . Numerous characteristic markers are also shared between the tumors of the two species such as CA-125 , CYP1B1 , E-cadherin  and COX-1 . The expression of COX-1 and accompanying high levels of prostaglandin E2 presents a target for dietary intervention with omega-3 fatty acids. Our one year study of hens fed a diet of 10% flaxseed showed reduction in cancer severity that corresponded to a reduction in prostaglandin levels . This suggests that ovarian cancer progression may be driven by inflammation. Our long term study in which hens were fed a diet supplemented with 10% flaxseed for four years resulted in a significant decrease in both incidence and severity of ovarian cancer . This suggests that in addition to decreased progression, initiation and/or promotion of this disease may be slowed by some component of flaxseed. This data is dually important in that it highlights the utility of the hen model for use in dietary studies of chemoprevention, and it provides strong evidence that dietary flaxseed significantly affects the initiation, promotion and progression of ovarian cancer. Thus, identification of the pathways altered by flaxseed may give insight into the etiology of the disease.
The objective of the current study was to identify possible targets and pathways affected by dietary flaxseed and by ovarian cancer to determine the mechanisms by which flaxseed confers chemoprotection against ovarian cancer. We performed a microarray analysis which compared normal ovaries and ovarian tumors from hens fed a control diet to those of hens fed a diet supplemented with 10% flaxseed. Microarray analysis was followed by comprehensive bioinformatics and several levels of experimental validation. This analysis revealed that pathways associated with branching morphogenesis are significantly increased in ovarian cancer and reduced by flaxseed, suggesting that the process driving tumor growth and progression toward a glandular morphology are targeted by the biologically active constituents of flaxseed.
Results and discussion
Flaxseed modulates genes linked to ovarian cancer in the laying hen
Microarray identification of genes responsive to flaxseed
Real time PCR validation corroborates flaxseed responsive genes found by microarray analysis
Genes included in PCR array
Fos and Jun dimerize to form AP-1, involved in cell proliferation, differentiation, and transformation
PCNA, proliferating cell nuclear antigen
DNA synthesis, cell-cycle control, and DNA-damage response and repair
CCND1, cyclin D1
Regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition
TERT1, telomerase reverse transcriptase
Maintains telomere ends, chromosomal repair
Transcription factor amplified or overexpressed in variety of tumors
Transcription factor activated upon various mitogenic signals such as Wnt, Shh and EGF
Transcription factor mediating sonic hedgehog signaling
Transcription factor with roles in embryonic development, cell fate determination, stem cell maintenance
Involved in the self-renewal of undifferentiated embryonic stem cells.
Indicator of stem-like capacity in embryonic stem cells
Endothelial cell mitogen
ANGPT1, angiopoietin 1
Involved in vascular development and angiogenesis
Scaffolding protein, possible tumor suppressor
Secreted signaling protein, activates beta catenin transcriptional activity
Secreted signaling protein, implicated in oncogenesis and in several developmental processes
Transcriptional repressor involved in epithelial-mesenchymal transitions and has antiapoptotic activity.
Member of a family of peptides that regulate proliferation, differentiation, adhesion, migration, and other functions in many cell types
IGF1, insulin like growth factor
Growth and anabolic effects
Cytokine regulates lymphocyte activity
PTGS1, COX1, prostaglandin G/H synthase and cyclooxygenase)
Converts arachidonic acid to prostaglandin
E-cadherin, PAX2, MSX2, FOXA2 and Engrailed-1are upregulated in hen ovarian cancer and decreased by dietary flaxseed
The microarray analysis and PCR array identified an additional group of genes that were upregulated in cancer and targeted by flaxseed. These were genes encoding transcription factors involved in early development, cell-fate determination and morphogenesis including PAX2, FOXA2, MSX2 and EN1. The expression of these genes was assayed in samples obtained from the five year study (Figure 5) . In agreement with data from both human  and chicken , we find PAX2 expression is upregulated 9-fold in ovarian cancer from control-fed hens compared to normal ovaries from control-fed hens. Additionally, we show that flaxseed attenuated this upregulation in ovarian tumors to 6-fold compared to normal ovaries. MSX2, a member of the muscle segment homeobox family, is upregulated 5-fold in ovarian tumors from control-fed hens compared to normal ovaries. Dietary flaxseed significantly decreased this upregulation to 2-fold in ovarian tumors. FOXA2 mRNA is aberrantly over-expressed 7-fold in ovarian tumors from control-fed hens. This upregulation is decreased by flaxseed to 4-fold in ovarian tumors compared to normal ovaries. Lastly, we show that tumors from control-fed hens exhibit a 6-fold upregulation of EN1 mRNA compared to normal ovaries, and this upregulation is decreased by flaxseed to 2-fold compared to normal ovaries. In addition, the flaxseed diet has an inhibitory effect on the expression of PAX2, MSX2 and E-cadherin mRNA in normal ovaries in the absence of pathology. That all of these genes are significantly downregulated in tumors from flax-fed hens suggests that they may play a role in the progression of the disease.
Immunohistochemical localization of PAX2, FOXA2 and EN1 reveals that they co-localize with E-cadherin in the glandular epithelial compartment of the ovarian tumor (Figure 6). No expression of these factors can be detected prior to the expression of E-cadherin in the cortical region of the ovary, nor do they co-localize with E-cadherin in the OSE. Three of these genes play an active role in normal gland morphogenesis. In the mouse, PAX2 protein is required for Mullerian duct formation, including ductal and mesenchymal elements . MSX2 expression has been reported to be increased in human ovarian endometrioid adenocarcinoma as a target of WNT signaling . It has also been shown to play a role in branching morphogenesis during mouse mammary gland development through the action of BMP signaling . It plays a role in both growth and apoptosis, particularly affecting the proliferative and regenerative capacity of tissue . FOXA2 plays a role in mouse lung morphogenesis  as well as chicken oviduct development , where it is modulated post-transcriptionally by estrogen. It promotes epithelialization during embryogenesis  and has been shown to directly  and indirectly  regulate E-cadherin expression. Engrailed has been best characterized in the Drosophila wing for its role as a segment polarity gene that transcriptionally activates Hedgehog, which in turn establishes the Decapentaplegic (BMP homolog) morphogen gradient . In mammals, EN2 has been shown to be dysregulated in bladder, ovarian and prostate cancers, whereas EN1 has been demonstrated in salivary gland adenoid cystic carcinoma . Interestingly, Engrailed can be secreted as well as taken up by cells and urinary EN2 levels have been proposed as a marker for prostate cancer . Although expression of these genes may suggest a cell or tissue of origin for ovarian cancer, an alternative interpretation may be the induction of a morphogenic process in the ovary to which a plastic transformed cell responds. Thus, EOC could conceivably develop in the ovary due to the activation of morphogens responsible for glandular differentiation acting on transformed cells. The parallel patterns of expression we observe in these genes in tumors from both control-fed and flax-fed hens suggests that formation of EOC is mediated in part by aberrant activation of a developmental program which controls branching morphogenesis, and that dietary flaxseed impedes or perturbs this program.
miR-200 family is upregulated in hen ovarian cancer compared to normal ovaries and is decreased by dietary flaxseed
Dietary flaxseed significantly decreases expression of miR-200 family in hen ovarian cancer, but does not affect expression of miR-200 family in normal ovaries. This observation is significant in its implication that some of the chemopreventive mechanisms of flaxseed function at the epigenetic regulatory level. Indeed, whole flaxseed contains elements that exert pleiotropic actions in cancer cells by functioning as antioxidant, anti-inflammatory, and anti-estrogenic agents.
Microarray analysis revealed that flaxseed downregulates certain genes associated with ovarian cancer development and progression, and that pathways known to be dysregulated in ovarian cancer are targets of flaxseed action. More importantly, these data support the idea that dietary manipulation can modulate epigenetic and transcriptional changes associated with cancer development and progression. Notably, flax affects a group of genes in tumors that control branching morphogenesis during gland development, including PAX2, FOXA2, MSX2 and EN1. Expression of these genes explains the glandular appearance of the tumors and is evidence of the process directing tumor growth, a process that involves proliferation and subsequent differentiation into glands. The upregulation of E-cadherin is a key feature of gland development and in these tumors is paralleled by the expression of miR-200 family members. Flaxseed downregulates all of these genes in a parallel fashion, suggesting a coordinated regulation, and without inducing an epithelial-mesenchymal transition; the epithelial morphology is maintained. Recently, stem-like epithelial cells have been identified in both ovarian surface epithelium and the distal cells of the tubal fimbriae [48, 49]. Induction of genes involved in glandular morphogenesis may drive these stem cells to proliferate and differentiate into the ovarian cortex in response to morphogens present in the cortex. We suggest that flaxseed reduces, but may not completely eliminate, signals from the cortex that are involved in the proliferative phase of the process of branching morphogenesis, leaving the ability to differentiate intact, thereby revealing molecular targets that will provide the foundation for clinical intervention studies.
Antibodies: E-cadherin (BD transduction laboratories), PAX2 (Invitrogen), Dylight-488 donkey anti-mouse IgG, Dylight-549 donkey anti-rabbit IgG and Alexafluor-549 donkey anti-mouse IgG (Jackson Immunoresearch), DAPI fluorescent mounting medium (Southern Biotech). The HNF3B (HC7) monoclonal antibody was developed by Thomas Jessel and Susan Brenner-Morton and the Engrailed-1 monoclonal antibody (4D9) was developed by Corey Goodman. Both were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Dept. of Biology, Iowa City, IA 52242.
Animal care and tissue collection
Single–comb White Leghorn hens were maintained as previously described [14, 50], with review and approval of the Institutional Animal Care and Use Committees at the University of Illinois at Urbana-Champaign and Southern Illinois University at Carbondale. The one year study included 387 2.5 year old hens and the five year study included 682 hens that aged 12–45 months. Hens were randomly divided into Control and Flax groups, where Control hens were fed a standard diet, while the Flax group was fed a diet supplemented with 10% flaxseed. Diet composition was previously described in detail . Upon necropsy, tissues were collected and processed as described .
Total RNA extraction and analysis
Total RNA was extracted from ovarian tissue that was either flash-frozen in liquid nitrogen, or stored in RNAlater (Invitrogen Life Technologies, Gaithersburg, MD). TRIzol reagent (Invitrogen) was used according to manufacturer′s instructions. Quantification of RNA was done using NanoDrop ND-1000 spectrophotometer measurement (NanoDrop Technologies). Integrity of total RNA was confirmed by Experion RNA StdSens Analysis (BioRad, Inc.). Biological replicates used in the microarray analysis were: 6 control normal replicates (C7,C8, C13, C22, C23, C31), 6 control cancer replicates (C16, C21, C30, C35, C60, C71), 6 flaxseed normal replicates (F1, F2, F5, F9, F20, F32) and 6 flaxseed cancer replicates (F11, F32, F36, F38, F86, F89) from the one year flaxseed study. The cancer replicates were of similar grade, stage and histotype.
Labeling and hybridization
The microarray procedure was conducted at the University of Illinois Urbana-Champaign at the Keck Center for Biotechnology. One microgram of total RNA was labeled using the Agilent two-color QuickAmp labeling kit (Agilent Technologies) according to the manufacturer’s protocol. Agilent custom 4x44K chicken long oligo microarray, designed by Dr. Zhou of Texas A&M University was utilized for the array analysis . Samples were hybridized using the In situ hybridization kit plus (Agilent Technologies, Palo Alto, CA, USA). Arrays were incubated at 65°C for 17 hours in Agilent’s microarray hybridization chambers. After hybridization, arrays were washed according to the Agilent protocol. Arrays were scanned at 5-μm resolution using an Axon GenePix 4000B scanner (Molecular Devices Corporation, Sunnyvale, CA) and images were saved as TIFF format. Images were quantified using Axon GenePix 6.0 (Molecular Devices Corporation, Downingtown, PA), and data were saved as .txt files for further analysis.
Data normalization and statistical analysis
Median foreground signal intensities (no background subtraction) were normalized using Locally Weighted Linear Regression (LOWESS) within the R statistics package (version 2.7.2) using the “VSN” method in limma (version 2.14.7) to remove signal intensity-dependent dye bias. Spots with -100 flags were weighted zero before normalization. P value and fold changes between each comparison for each gene were calculated. Microarray data are MIAME compliant and available in Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) through the accession number GSE40376. Differentially expressed genes were identified by setting the significance level to a false discovery rate of <0.1.
Annotations were done using Database for Annotation, Visualization and Integrated Discovery (DAVID) tool [51, 52]. We applied various bioinformatics tools such as Multiple Experimental Viewer for the heatmap , and Ingenuity Pathway Analysis (Ingenuity® Systems, http://www.ingenuity.com). Functional classification of these genes was carried out using the gene expression analysis tool PANTHER (Protein ANalysis THrough Evolutionary Relationships) [54, 55] and Gene Ontology Enrichment Analysis Software Toolkit  for analysis.
Microarray data sorting and gene expression analysis
Comparing the gene expression levels of the groups, the threshold level was set at >2 and <2 fold differences for the analysis. Differentially expressed genes in control-cancer vs. control-normal (CC-CN) and flax-cancer vs. flax-normal (FC-FN) constituted primary gene dataset. Then these primary datasets of CC-CN and FC-FN were compared which resulted in a secondary dataset consisting of 324 common and 287 uncommon genes of these two groups. The common genes signify that these genes are crucial in cancer progression and unaffected by flaxseed, whereas uncommon genes present in CC-CN group may be possible targets of flaxseed. To identify these potential flaxseed target genes, the uncommon genes in CC-CN were compared with flax-normal vs control-normal (FN-CN) dataset which generated a final list of 118 common genes.
Four biological replicate samples from control-normal, control-cancer, flax-normal and flax-cancer were used for analysis. Total RNA was transcribed into cDNA using qScript DNA supermix. A customized 384 well StellARray (Cat#00194810) for Gallus gallus was purchased from Bar Harbor BioTechnology. A total of 44 target genes (including 4 housekeeping genes) were selected for analysis. Real-time PCR was performed using cDNA and EvaGeen mix (BioRad, Inc.) in a 384 well plate with primer mix for selected genes. The reaction and signal were measured using BioRad CFX manager software (BioRad Inc.). The expression levels were calculated as relative expression normalized to the expression levels of the housekeeping genes TATA box binding protein 1 (TBP1), Ribosomal protein L4 (RPL4), Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and Succinate dehydrogenase complex, subunit A (SDHA).
cDNA Synthesis and qPCR analysis of mRNA Targets
First-strand cDNA synthesis was performed using total RNA and qScript cDNA Supermix (Quanta Biosciences 95048) according to manufacturer’s instructions. qPCR was performed using SsoFast EvaGreen Supermix (BioRad 172–5203). Reactions were 10ul and used 400 nm symmetric primer mix. Amplification conditions were as follows: 95C 5 s, 40 cycles for 95C 5 s, 58-68C 2 s. Expression analysis was performed using BioRad CFX Manager Software. mRNA levels were normalized to two stably expressed reference genes, SDHA and RPL4.
Ovary tissue was collected from hens in the five year study, processed, fixed in NBF and paraffin-embedded as previously described . Five micrometer sections were mounted onto charged Superfrost slides, deparaffined in xylene and rehydrated in graded ethanol solutions. Antigen retrieval was performed by heating slides under pressure of 15 psi in 0.1 M sodium citrate for 20 minutes. Slides were blocked with phosphate buffered saline/0.1% Tween-20 (PBST) and 5% fetal calf serum for 2 hours. Following blocking, sections stained for PAX2 and E-cadherin were incubated overnight with both rabbit anti-mouse PAX2 at 1:200 and mouse anti-human E-cadherin at 1:500 in PBST with 5% fetal calf serum. Slides were washed in PBST and incubated with both Dylight-488 donkey anti-mouse IgG and Dylight-549 donkey anti-rabbit IgG) at 1:200 for 2 hours. Sections stained for E-cadherin/EN-1 and E-cadherin/FOXA2 were incubated with anti- E-cadherin overnight, washed in PBST and then incubated with Alexafluor-549 donkey anti-mouse IgG at 1:200 for 2 hours. A second overnight incubation with either anti-HNF3beta or anti-Engrailed-1 at 1:10 in PBST and 5% fetal calf serum, followed by incubation with Dylight 488-conjugated donkey anti-mouse IgG at 1:200 for 2 hours completed the double-labeling. All slides were mounted with DAPI fluorescent mounting medium and visualized by confocal microscopy using a Leica model DM5500Q microscope using filters A4, Y5,and L5, and images were captured with a Leica DFC365 FX camera. Dual images were produced using Leica Application Suite-Advanced fluorescence version 126.96.36.19966.
Total RNA was isolated from flash-frozen ovary tissue from the five year study using Tri Reagent (Ambion). First-strand cDNA synthesis was performed using Universal cDNA synthesis kit (Exiqon 203301). miRNA expression was quantified using SYBR Green master mix, Universal RT kit (Exiqon 203420). Locked nucleic acid primers for miR-200a (Exiqon 204707), miR-200b (custom Exiqon primer set), and miR-429 (Exiqon 205068) were used for quantification. qPCR values were normalized to two reference miRNAs stably expressed across the sample population, miR-460 (Exiqon) and miR-455 (Exiqon). Six samples were analyzed per group. Statistical analysis using one-way ANOVA followed by Student–Newman-Keuls post test was performed using GraphPad Instat program. p values of 0.05 or less were considered significant.
miRNA in situhybridization
In situ hybridization for miR-200a was performed as previously described  with modifications. Briefly, formalin-fixed, paraffin-embedded tissues from the five year study were sectioned at 5 micrometers and mounted onto positively-charged Superfrost slides. Sections were deparaffined in Histoclear and rehydrated through graded ethanol solutions. Sections were then digested with proteinase K (20ug/ml for 15 minutes) and acetylated. miR-200a double-DIG-labeled LNA probe (Exiqon) was diluted to 20 nM in hybridization buffer (Roche) and sections were hybridized overnight at 54°C. Following stringency washes, sections were blocked and incubated with goat anti-digoxin antibody conjugated to AP at 1:500 for 16 hours. Color development was performed using BCIP/NBT (Roche) in NTMT, 10% PVA and Levamisole (Sigma) for 30 hours. Sections were counterstained with nuclear fast red and mounted for visualization using a Leica model DM IL microscope and DFC 400 camera.
Availability of supporting data
Microarray data are MIAME compliant and available in Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) through the accession number GSE40376.
We wish to thank Dr. Sharon Stack for her critical reading of the manuscript, and Stacey McGee for the Zeb1 immunohistochemistry.
This work was supported by NIH/NCCAM AT005295 (DBH), NIH/NCCAM AT004085 (DBH); NIH/NCI CA133915 (DBH), Art Erhmann Cancer Fund, Fraternal Order of Eagles (KHH) and startup funds from Southern Illinois University School of Medicine (KHH).
- Vaughan S, Coward JI, Bast RC, Berchuck A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R, Etemadmoghadam D, Friedlander M, Gabra H, Kaye SB, Lord CJ, Lengyel E, Levine DA, McNeish IA, Menon U, Mills GB, Nephew KP, Oza AM, Sood AK, Stronach EA, Walczak H, Bowtell DD, Balkwill FR: Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011, 11 (10): 719-725. 10.1038/nrc3144.PubMed CentralPubMedView ArticleGoogle Scholar
- Wiseman M: The second world cancer research fund/American institute for cancer research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008, 67 (03): 253-256. 10.1017/S002966510800712X.PubMedView ArticleGoogle Scholar
- Coussens LM, Werb Z: Inflammation and cancer. Nature. 2002, 420 (6917): 860-867. 10.1038/nature01322.PubMed CentralPubMedView ArticleGoogle Scholar
- Wang L-Q: Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr B. 2002, 777 (1–2): 289-309.Google Scholar
- Johnson PA, Giles JR: The hen as a model of ovarian cancer. Nat Rev Cancer. 2013, 13 (6): 432-436. 10.1038/nrc3535.PubMedView ArticleGoogle Scholar
- Lengyel E, Burdette JE, Kenny HA, Matei D, Pilrose J, Haluska P, Nephew KP, Hales DB, Stack MS: Epithelial ovarian cancer experimental models. Oncogene. 2013, August 12 [Epub ahead of print]Google Scholar
- Fredrickson TN: Ovarian tumors of the hen. Environ Health Perspect. 1987, 73: 35-51.PubMed CentralPubMedView ArticleGoogle Scholar
- Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, Bradaric MJ, Edassery SL, Rotmensch J, Luborsky JL: Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer. 2009, 19 (4): 531-539. 10.1111/IGC.0b013e3181a41613.PubMed CentralPubMedView ArticleGoogle Scholar
- Hakim AA, Barry CP, Barnes HJ, Anderson KE, Petitte J, Whitaker R, Lancaster JM, Wenham RM, Carver DK, Turbov J, Berchuck A, Kopelovich L, Rodriguez GC: Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev Res (Phila). 2009, 2 (2): 114-121. 10.1158/1940-6207.CAPR-08-0065.View ArticleGoogle Scholar
- Jackson E, Anderson K, Ashwell C, Petitte J, Mozdziak PE: CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol Oncol. 2007, 104 (1): 192-198. 10.1016/j.ygyno.2006.07.024.PubMedView ArticleGoogle Scholar
- Zhuge Y, Lagman JA, Ansenberger K, Mahon CJ, Daikoku T, Dey SK, Bahr JM, Hales DB: CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus. Gynecol Oncol. 2009, 112 (1): 171-178. 10.1016/j.ygyno.2008.09.026.PubMed CentralPubMedView ArticleGoogle Scholar
- Ansenberger K, Zhuge Y, Lagman JA, Richards C, Barua A, Bahr JM, Hales DB: E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecol Oncol. 2009, 113 (3): 362-369. 10.1016/j.ygyno.2009.02.011.PubMed CentralPubMedView ArticleGoogle Scholar
- Hales DB, Zhuge Y, Lagman JA, Ansenberger K, Mahon C, Barua A, Luborsky JL, Bahr JM: Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus). Endocrine. 2008, 33 (3): 235-244. 10.1007/s12020-008-9080-z.PubMed CentralPubMedView ArticleGoogle Scholar
- Ansenberger K, Richards C, Zhuge Y, Barua A, Bahr JM, Luborsky JL, Hales DB: Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed-enriched diet for 1 year. Gynecol Oncol. 2010, 117 (2): 341-347. 10.1016/j.ygyno.2010.01.021.PubMed CentralPubMedView ArticleGoogle Scholar
- Eilati E, Bahr JM, Hales DB: Long term consumption of flaxseed enriched diet decreased ovarian cancer incidence and prostaglandin E2 in hens. Gynecol Oncol. 2013, 130 (3): 620-628. 10.1016/j.ygyno.2013.05.018.PubMedView ArticleGoogle Scholar
- Li X, Chiang HI, Zhu J, Dowd SE, Zhou H: Characterization of a newly developed chicken 44 K Agilent microarray. BMC Genomics. 2008, 9: 60-10.1186/1471-2164-9-60.PubMed CentralPubMedView ArticleGoogle Scholar
- Landen CN, Birrer MJ, Sood AK: Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol. 2008, 26 (6): 995-1005. 10.1200/JCO.2006.07.9970.PubMedView ArticleGoogle Scholar
- Zhang J, Chen YH, Lu Q: Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy. Future Oncol. 2010, 6 (4): 587-603. 10.2217/fon.10.15.PubMed CentralPubMedView ArticleGoogle Scholar
- Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144 (5): 646-674. 10.1016/j.cell.2011.02.013.PubMedView ArticleGoogle Scholar
- Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006, 126 (4): 663-676. 10.1016/j.cell.2006.07.024.PubMedView ArticleGoogle Scholar
- Hudson LG, Zeineldin R, Stack MS: Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clin Exp Metastasis. 2008, 25 (6): 643-655. 10.1007/s10585-008-9171-5.PubMed CentralPubMedView ArticleGoogle Scholar
- Ansenberger K: The Laying hen and Flaxseed: A Model for Dietary Intervention of Human Ovarian Cancer. Ph.D. 2010, Chicago: University of Illinois at Chicago, Health Sciences CenterGoogle Scholar
- Torres M, Gomez-Pardo E, Dressler GR, Gruss P: Pax-2 controls multiple steps of urogenital development. Development. 1995, 121 (12): 4057-4065.PubMedGoogle Scholar
- Bazer FW: Uterine adenogenesis and pregnancy: multiple roles for Foxa2 in mice. Biol Reprod. 2010, 83 (3): 319-321. 10.1095/biolreprod.110.086694.PubMedView ArticleGoogle Scholar
- Satoh K, Ginsburg E, Vonderhaar BK: Msx-1 and Msx-2 in mammary gland development. J Mammary Gland Biol Neoplasia. 2004, 9 (2): 195-205.PubMedView ArticleGoogle Scholar
- Logan C, Hornbruch A, Campbell I, Lumsden A: The role of Engrailed in establishing the dorsoventral axis of the chick limb. Development. 1997, 124 (12): 2317-2324.PubMedGoogle Scholar
- Tung CS, Mok SC, Tsang YT, Zu Z, Song H, Liu J, Deavers MT, Malpica A, Wolf JK, Lu KH, Gershenson DM, Wong KK: PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Mod Pathol. 2009, 22 (9): 1243-1250. 10.1038/modpathol.2009.92.PubMed CentralPubMedView ArticleGoogle Scholar
- Trevino LS, Giles JR, Wang W, Urick ME, Johnson PA: Gene expression profiling reveals differentially expressed genes in ovarian cancer of the hen: support for oviductal origin?. Horm Cancer. 2010, 1 (4): 177-186. 10.1007/s12672-010-0024-8.PubMedView ArticleGoogle Scholar
- Zhai Y, Iura A, Yeasmin S, Wiese AB, Wu R, Feng Y, Fearon ER, Cho KR: MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma. Oncogene. 2011, 30 (40): 4152-4162. 10.1038/onc.2011.123.PubMed CentralPubMedView ArticleGoogle Scholar
- Bendall AJ, Abate-Shen C: Roles for Msx and Dlx homeoproteins in vertebrate development. Gene. 2000, 247 (1–2): 17-31.PubMedView ArticleGoogle Scholar
- Wan H, Dingle S, Xu Y, Besnard V, Kaestner KH, Ang S-L, Wert S, Stahlman MT, Whitsett JA: Compensatory Roles of Foxa1 and Foxa2 during Lung Morphogenesis. J Biol Chem. 2005, 280 (14): 13809-13816. 10.1074/jbc.M414122200.PubMedView ArticleGoogle Scholar
- Berger RR, Sanders MM: Estrogen modulates HNF-3beta mRNA levels in the developing chick oviduct. DNA Cell Biol. 2000, 19 (2): 103-112. 10.1089/104454900314618.PubMedView ArticleGoogle Scholar
- Burtscher I, Lickert H: Foxa2 regulates polarity and epithelialization in the endoderm germ layer of the mouse embryo. Development. 2009, 136 (6): 1029-1038. 10.1242/dev.028415.PubMedView ArticleGoogle Scholar
- Liu Y-N, Lee W-W, Wang C-Y, Chao T-H, Chen Y, Chen JH: Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene. 2005, 24 (56): 8277-8290. 10.1038/sj.onc.1208991.PubMedView ArticleGoogle Scholar
- Song Y, Washington MK, Crawford HC: Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res. 2010, 70 (5): 2115-2125. 10.1158/0008-5472.CAN-09-2979.PubMed CentralPubMedView ArticleGoogle Scholar
- Hidalgo A: Growth and patterning from the engrailed interface. Int J Dev Biol. 1998, 42 (3): 317-324.PubMedGoogle Scholar
- McGrath SE, Michael A, Pandha H, Morgan R: Engrailed homeobox transcription factors as potential markers and targets in cancer. FEBS Lett. 2013, 587 (6): 549-554. 10.1016/j.febslet.2013.01.054.PubMedView ArticleGoogle Scholar
- Morgan R, Boxall A, Bhatt A, Bailey M, Hindley R, Langley S, Whitaker HC, Neal DE, Ismail M, Whitaker H, Annels N, Michael A, Pandha H: Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer. Clin Cancer Res. 2011, 17 (5): 1090-1098. 10.1158/1078-0432.CCR-10-2410.PubMedView ArticleGoogle Scholar
- van Jaarsveld MT, Helleman J, Berns EM, Wiemer EA: MicroRNAs in ovarian cancer biology and therapy resistance. Int J Biochem Cell Biol. 2010, 42 (8): 1282-1290. 10.1016/j.biocel.2010.01.014.PubMedView ArticleGoogle Scholar
- Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O, Nicolas A, Meyniel J-P, Cottu P, Sastre-Garau X, Mechta-Grigoriou F: miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med. 2011, 17 (12): 1627-1635. 10.1038/nm.2512.PubMedView ArticleGoogle Scholar
- Prasad K: Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, Enterodiol, and enterolactone. Int J Angiol. 2000, 9 (4): 220-225. 10.1007/BF01623898.PubMedView ArticleGoogle Scholar
- Kivelä AM, Kansanen E, Jyrkkänen H-K, Nurmi T, Ylä-Herttuala S, Levonen A-L: Enterolactone induces heme oxygenase-1 expression through nuclear factor-E2-related factor 2 activation in endothelial cells. J Nutr. 2008, 138 (7): 1263-1268.PubMedGoogle Scholar
- Parasramka MA, Ho E, Williams DE, Dashwood RH: MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals. Mol Carcinog. 2012, 51 (3): 213-230. 10.1002/mc.20822.PubMed CentralPubMedView ArticleGoogle Scholar
- Cano A, Nieto MA: Non-coding RNAs take centre stage in epithelial-to-mesenchymal transition. Trends Cell Biol. 2008, 18 (8): 357-359. 10.1016/j.tcb.2008.05.005.PubMedView ArticleGoogle Scholar
- Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T: A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9 (6): 582-589. 10.1038/embor.2008.74.PubMed CentralPubMedView ArticleGoogle Scholar
- Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008, 10 (5): 593-601. 10.1038/ncb1722.PubMedView ArticleGoogle Scholar
- Park SM, Gaur AB, Lengyel E, Peter ME: The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22 (7): 894-907. 10.1101/gad.1640608.PubMed CentralPubMedView ArticleGoogle Scholar
- Auersperg N: The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae. Int J Gynecol Pathol. 2013, 32 (5): 444-453. 10.1097/PGP.0b013e3182800ad5.PubMedView ArticleGoogle Scholar
- Paik DY, Janzen DM, Schafenacker AM, Velasco VS, Shung MS, Cheng D, Huang J, Witte ON, Memarzadeh S: Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation. Stem Cells. 2012, 30 (11): 2487-2497. 10.1002/stem.1207.PubMed CentralPubMedView ArticleGoogle Scholar
- Eilati E, Pan L, Bahr JM, Hales DB: Age dependent increase in prostaglandin pathway coincides with onset of ovarian cancer in laying hens. Prostaglandins Leukot Essent Fatty Acids. 2012, 87 (6): 177-184. 10.1016/j.plefa.2012.09.003.PubMed CentralPubMedView ArticleGoogle Scholar
- da Huang W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009, 4 (1): 44-57.PubMedView ArticleGoogle Scholar
- da Huang W, Sherman BT, Lempicki RA: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37 (1): 1-13. 10.1093/nar/gkn923.PubMedView ArticleGoogle Scholar
- Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J: TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003, 34 (2): 374-378.PubMedGoogle Scholar
- Mi H, Thomas P: PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol. 2009, 563: 123-140. 10.1007/978-1-60761-175-2_7.PubMedView ArticleGoogle Scholar
- Mi H, Muruganujan A, Casagrande JT, Thomas PD: Large-scale gene function analysis with the PANTHER classification system. Nat Protoc. 2013, 8 (8): 1551-1566. 10.1038/nprot.2013.092.PubMedView ArticleGoogle Scholar
- Zheng Q, Wang XJ: GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Nucleic Acids Res. 2008, 36 (Web Server issue): W358-W363.PubMed CentralPubMedView ArticleGoogle Scholar
- Bany B, Simmons D: Non-Radioactive in Situ Hybridizaion: Optimization for Tissue Sections from Pregnant Uteri and Placenta During the First Half of Pregnancy. The Guide for Investigation of Mouse Pregnancy. Edited by: Croy B, Yamada A, DeMayo F, Adamson S. 2013, Amsterdam: Elsevier, 591-603.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.